JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

JNJ

167.69

-0.36%↓

NVS

116.94

-0.3%↓

ABT

128.18

+0.74%↑

MDT

92.11

-0.35%↓

ELV.US

287.61

-2.37%↓

Search

Certara Inc

Deschisă

SectorSănătate

10.41 -2.89

Rezumat

Modificarea prețului

24h

Curent

Minim

10.38

Maxim

10.81

Indicatori cheie

By Trading Economics

Venit

-1.8M

4.7M

Vânzări

5.6M

106M

EPS

0.029

Marjă de profit

4.474

Angajați

1,487

EBITDA

-25M

609K

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+33.24% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-302M

1.8B

Deschiderea anterioară

13.3

Închiderea anterioară

10.41

Sentimentul știrilor

By Acuity

50%

50%

157 / 375 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Certara Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 iul. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

EQT: To Spend Y407.82B for Tender Offer

29 iul. 2025, 23:56 UTC

Achiziții, Fuziuni, Preluări

EQT: Tender Offer Price Is Y5,700 a Share

29 iul. 2025, 23:54 UTC

Achiziții, Fuziuni, Preluări

EQT To Start Tender Offer for Fujitec

29 iul. 2025, 23:50 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 iul. 2025, 23:36 UTC

Market Talk

Gold Steady Ahead of FOMC Decision -- Market Talk

29 iul. 2025, 22:57 UTC

Market Talk

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 iul. 2025, 22:50 UTC

Market Talk

Mondelez Warns of Price Increases in North America -- Market Talk

29 iul. 2025, 22:44 UTC

Achiziții, Fuziuni, Preluări

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 iul. 2025, 22:41 UTC

Achiziții, Fuziuni, Preluări

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 iul. 2025, 22:41 UTC

Achiziții, Fuziuni, Preluări

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Maintains Nova Life of Mine Production Guidance

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 iul. 2025, 22:35 UTC

Câștiguri

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 iul. 2025, 22:34 UTC

Câștiguri

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 iul. 2025, 22:34 UTC

Câștiguri

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 iul. 2025, 22:34 UTC

Market Talk
Câștiguri

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 iul. 2025, 22:33 UTC

Câștiguri

IGO Had A$279.7 Million of Cash at End-June

29 iul. 2025, 22:33 UTC

Câștiguri

IGO 4Q Underlying Free Cash A$2.4 Million

29 iul. 2025, 22:33 UTC

Câștiguri

IGO FY Sales Revenue A$512.5 Million

29 iul. 2025, 22:33 UTC

Câștiguri

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 iul. 2025, 22:32 UTC

Câștiguri

IGO FY Nickel Production 17,173 Tons

29 iul. 2025, 22:32 UTC

Câștiguri

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 iul. 2025, 22:32 UTC

Câștiguri

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 iul. 2025, 22:31 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

29 iul. 2025, 22:31 UTC

Market Talk
Câștiguri

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 iul. 2025, 22:31 UTC

Câștiguri

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 iul. 2025, 22:31 UTC

Câștiguri

IGO FY Spodumene Production 1.48 Million Tons

29 iul. 2025, 22:30 UTC

Câștiguri

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 iul. 2025, 22:30 UTC

Câștiguri

IGO 4Q Underlying Ebitda A$62 Million

29 iul. 2025, 22:22 UTC

Câștiguri

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Comparație

Modificare preț

Certara Inc Așteptări

Obiectiv de preț

By TipRanks

33.24% sus

Prognoză pe 12 luni

Medie 14.75 USD  33.24%

Maxim 16 USD

Minim 13 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCertara Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

6 ratings

2

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

11.27 / 12.79Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

157 / 375 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.